Cargando…

Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand

The positive predictive value of newborn screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency was <2% in New Zealand. This is despite a bloodspot second-tier immunoassay method for 17-hydroxyprogesterone measurement with an additional solvent extract step to reduce the nu...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Hora, Mark R., Heather, Natasha L., Patel, Tejal, Bresnahan, Lauren G., Webster, Dianne, Hofman, Paul L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422986/ https://www.ncbi.nlm.nih.gov/pubmed/33073005 http://dx.doi.org/10.3390/ijns6010006

Ejemplares similares

First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency
por: Itonaga, Tomoyo, et al.
Publicado: (2022)

Newborn Screening for CAH—Challenges and Opportunities
por: Heather, Natasha L., et al.
Publicado: (2021)

High-Dose Hook Effect in 17-Hydroxyprogesterone Assay in a Patient with 21-Hydroxylase Deficiency
por: Parlak, Mesut, et al.
Publicado: (2015)

Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand
por: de Hora, Mark R., et al.
Publicado: (2022)

Prevalence of CAH-X Syndrome in Italian Patients with Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency
por: Paragliola, Rosa Maria, et al.
Publicado: (2022)

Introducing Newborn Screening for Severe Combined Immunodeficiency—The New Zealand Experience
por: Heather, Natasha, et al.
Publicado: (2022)

Data on the functional consequences of the mutations identified in 21-Hydroxylase deficient CAH patients
por: Khajuria, Ragini, et al.
Publicado: (2018)

Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany
por: Dörr, Helmuth G., et al.
Publicado: (2018)

Data on the 21-Hydroxylase deficient CAH patients and the identification of known/novel mutations in CYP21A2 gene
por: Khajuria, Ragini, et al.
Publicado: (2016)

Molecular basis and genetic testing strategies for diagnosing 21-hydroxylase deficiency, including CAH-X syndrome
por: Kim, Ja Hye, et al.
Publicado: (2023)

The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives
por: de Hora, Mark, et al.
Publicado: (2023)

CAH Newborn Screening in India: Challenges and Opportunities
por: Dabas, Aashima, et al.
Publicado: (2020)

Molecular genetic testing of congenital adrenal hyperplasia due to 21-hydroxylase deficiency should include CAH-X chimeras
por: Lao, Qizong, et al.
Publicado: (2021)

SUN-LB11 What Is the Value of Clinical Suspicion in Neonatal Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (CAH 21OHD)?
por: Fernández, María Sanz, et al.
Publicado: (2020)

Co-production of 11α-hydroxyprogesterone and ethanol using recombinant yeast expressing fungal steroid hydroxylases
por: Hull, Claire M., et al.
Publicado: (2017)

Measurement of Serum 17α-hydroxyprogesterone in Newborn Infants by Stable Isotope Dilution—Gas Chromatography/Mass Spectrometry
por: Homma, Keiko, et al.
Publicado: (2009)

21-Hydroxylase Deficiency: Newborn Screening in Iran?
por: Mahdieh, Nejat, et al.
Publicado: (2012)

The risk of classical galactosaemia in newborns with borderline galactose metabolites on newborn screening
por: Bernhardt, Isaac, et al.
Publicado: (2022)

Relationships of Basal Level of Serum 17-Hydroxyprogesterone with that of Serum Androstenedione and Their Stimulated Responses to a Low Dose of ACTH in Young Adult Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
por: Kang, Min Jae, et al.
Publicado: (2011)

Growth-Related Characteristics of Patients <18 Years of Age with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (21OHD): Real World Evidence from the I-CAH Registry
por: Farrar, Mallory, et al.
Publicado: (2021)

The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
por: Ransom, Carla E., et al.
Publicado: (2011)

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
por: Teti, Claudia, et al.
Publicado: (2023)

Introduction of a Protocol for Structured Follow-Up and Texting of Inadequate and Borderline-Positive Newborn Metabolic Screening Results
por: Heather, Natasha, et al.
Publicado: (2022)

Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
por: Sexton, Donal J, et al.
Publicado: (2004)

Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth
por: Alizadeh, Fahimeh, et al.
Publicado: (2022)

Cortisol, progesterone, 17α-hydroxyprogesterone, and TSH responses in dogs injected with low-dose lipopolysaccharide
por: Corder-Ramos, Nicole L.B., et al.
Publicado: (2019)

Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan
por: Tsuji-Hosokawa, Atsumi, et al.
Publicado: (2021)

Diagnosis and prevalence of Congenital Adrenal Hyperplasia (CAH) in Austrian children screened or not screened for CAH
por: Luxenberger, Katharina, et al.
Publicado: (2013)

The impact of neonatal 17-hydroxyprogesterone cutoff determination in a public newborn screening program for congenital adrenal hyperplasia in Southern Brazil: 3 years’ experience
por: de Castro, Simone Martins, et al.
Publicado: (2023)

Manuscrito de Chan Cah.
Publicado: (1982)

An integrated PK‐PD model for cortisol and the 17‐hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia
por: Al‐Kofahi, Mahmoud, et al.
Publicado: (2020)

Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support
por: SATIR, FUNDA, et al.
Publicado: (2013)

Individual 17-Hydroxyprogesterone Responses to hCG Are Not Correlated With Follicle Size in Polycystic Ovary Syndrome
por: Homer, Michael V, et al.
Publicado: (2019)

Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?
por: Cohen, Gal, et al.
Publicado: (2022)

Diagnosis and management of rare forms of CAH
por: Sahakitrungruang, Taninee
Publicado: (2015)

Should CAH in Females Be Classified as DSD?
por: González, Ricardo, et al.
Publicado: (2016)

Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection
por: Chollet, John L., et al.
Publicado: (2012)

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Zetterström, Rolf H., et al.
Publicado: (2020)

17-hydroxyprogesterone quantification in dried blood spots by high performance liquid chromatography-tandem mass spectroscopy
por: Waller, Kate, et al.
Publicado: (2015)

Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-alpha-Hydroxyprogesterone Caproate
por: Egerman, Robert, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8rrs40gm5lf3d41oir88p11ij4